Michael Terao1, James M Hoffman2, Richard J Brilli3, Amanda Finch4, Kathleen E Walsh5, Maitreya Coffey4,6. 1. Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN. 2. Office of Quality and Patient Care and Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN. 3. Nationwide Children's Hospital; Pediatrics, Ohio State University College of Medicine, Columbus, OH. 4. Children's Hospitals' Solutions for Patient Safety and Cincinnati Children's, Cincinnati, OH. 5. MD, MS, James M Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital, Cincinnati, OH. 6. The Hospital for Sick Children, Toronto, Ontario, Canada.
Abstract
PURPOSE OF REVIEW: Quality improvement collaboratives can accelerate quality improvement and patient safety efforts. We reviewed major pediatric quality improvement collaboratives that have published results in the past five years and discussed common success factors and barriers encountered by these collaboratives. RECENT FINDINGS: Many pediatric quality improvement collaboratives are active in neonatal, cystic fibrosis, congenital heart disease, hematology/oncoogy, chronic kidney disease, rheumatology, critical care, and general pediatric care. SUMMARY: Factors important to the success of these pediatric quality improvement collaboratives include data sharing and communication, trust among institutions, financial support, support from national organizations, use of a theoretical framework to guide collaboration, patient and family involvement, and incentives for participation at both the individual and institutional levels. Common barriers encountered by these collaboratives include insufficient funding or resources, legal concerns, difficulty coming to consensus on best practices and outcome measures, and overcoming cultural barriers to change. Learning from the successes and challenges encountered by these collaboratives will enable the pediatric healthcare quality improvement community to continue to evolve this approach to maximize benefits to children.
PURPOSE OF REVIEW: Quality improvement collaboratives can accelerate quality improvement and patient safety efforts. We reviewed major pediatric quality improvement collaboratives that have published results in the past five years and discussed common success factors and barriers encountered by these collaboratives. RECENT FINDINGS: Many pediatric quality improvement collaboratives are active in neonatal, cystic fibrosis, congenital heart disease, hematology/oncoogy, chronic kidney disease, rheumatology, critical care, and general pediatric care. SUMMARY: Factors important to the success of these pediatric quality improvement collaboratives include data sharing and communication, trust among institutions, financial support, support from national organizations, use of a theoretical framework to guide collaboration, patient and family involvement, and incentives for participation at both the individual and institutional levels. Common barriers encountered by these collaboratives include insufficient funding or resources, legal concerns, difficulty coming to consensus on best practices and outcome measures, and overcoming cultural barriers to change. Learning from the successes and challenges encountered by these collaboratives will enable the pediatric healthcare quality improvement community to continue to evolve this approach to maximize benefits to children.
Authors: Stacey L Lihn; John D Kugler; Laura E Peterson; Carole M Lannon; Diane Pickles; Robert H Beekman Journal: Congenit Heart Dis Date: 2015-11-11 Impact factor: 2.007
Authors: Henry C Lee; Mihoko V Bennett; Margaret Crockett; Ruth Crowe; Steven G Gwiazdowski; Heather Keller; Paul Kurtin; Michael Kuzniewicz; Ann Marie Mazzeo; Joseph Schulman; Courtney C Nisbet; Paul J Sharek Journal: Pediatrics Date: 2018-06-13 Impact factor: 7.124
Authors: Sharon B Meropol; Nicholas K Schiltz; Abdus Sattar; Kurt C Stange; Ann H Nevar; Christina Davey; Gerald A Ferretti; Diana E Howell; Robyn Strosaker; Pamela Vavrek; Samantha Bader; Mary C Ruhe; Leona Cuttler Journal: Pediatrics Date: 2014-05-05 Impact factor: 7.124
Authors: Amy J Starmer; Nancy D Spector; Rajendu Srivastava; Daniel C West; Glenn Rosenbluth; April D Allen; Elizabeth L Noble; Lisa L Tse; Anuj K Dalal; Carol A Keohane; Stuart R Lipsitz; Jeffrey M Rothschild; Matthew F Wien; Catherine S Yoon; Katherine R Zigmont; Karen M Wilson; Jennifer K O'Toole; Lauren G Solan; Megan Aylor; Zia Bismilla; Maitreya Coffey; Sanjay Mahant; Rebecca L Blankenburg; Lauren A Destino; Jennifer L Everhart; Shilpa J Patel; James F Bale; Jaime B Spackman; Adam T Stevenson; Sharon Calaman; F Sessions Cole; Dorene F Balmer; Jennifer H Hepps; Joseph O Lopreiato; Clifton E Yu; Theodore C Sectish; Christopher P Landrigan Journal: N Engl J Med Date: 2014-11-06 Impact factor: 91.245
Authors: Wallace Crandall; Michael D Kappelman; Richard B Colletti; Ian Leibowitz; John E Grunow; Sabina Ali; Howard I Baron; James H Berman; Brendan Boyle; Stanley Cohen; Fernando del Rosario; Lee A Denson; Lynn Duffy; Mark J Integlia; Sandra C Kim; David Milov; Ashish S Patel; Bess T Schoen; Dorota Walkiewicz; Peter Margolis Journal: Inflamm Bowel Dis Date: 2011-01 Impact factor: 5.325
Authors: Amy L Billett; Richard B Colletti; Keith E Mandel; Marlene Miller; Stephen E Muething; Paul J Sharek; Carole M Lannon Journal: Pediatrics Date: 2013-06 Impact factor: 7.124
Authors: Maria T Britto; Sandra C Fuller; Heather C Kaplan; Uma Kotagal; Carole Lannon; Peter A Margolis; Stephen E Muething; Pamela J Schoettker; Michael Seid Journal: BMJ Qual Saf Date: 2018-02-05 Impact factor: 7.035
Authors: M Eva Dye; Caitlin Pugh; Christa Sala; Theresa A Scott; Tamara Wallace; Peter H Grubb; L Dupree Hatch Journal: Jt Comm J Qual Patient Saf Date: 2021-06-18